Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Member Advantages

Take the Next Step in Your Career at the FREE Virtual Career Fair!
Join the American Urological Association Virtual Career Fair, taking place November 7, 2024 from 5:30 - 7:30 p.m. ET. Attendees can pre-book appointments with individual employers to make the most of your time. Or, explore all opportunities in a more casual setting. Register Now
Free CME Webcast Now Available to Stream On-Demand!
Featuring a multidisciplinary panel of experts, you don't want to miss Prostate Cancer Update 2024: Expert Guidance for Urologists! This engaging discussion provides critical updates for urologists on the latest advancements in managing the spectrum of Hormone-Sensitive Prostate Cancer (HSPC). Stream Today
Applications Now Open for the AUA Leadership Program
Join the AUA Leadership Program—an exciting chance for urologists to enhance their leadership skills and influence the future of organized medicine! This dynamic year-long program selects top applicants from each AUA Section, offering a competitive platform for growth. Don’t miss your opportunity to be among the next generation of AUA leaders. Apply Today

Latest from Journals

JU | September 2024

Development of a Novel Prediction Tool for Response to First-Line Treatments of Monosymptomatic Nocturnal Enuresis: A Randomized, Controlled, International, Multicenter Study (DRYCHILD)

Nocturnal urine volume and bladder reservoir function are key pathogenic factors behind monosymptomatic nocturnal enuresis (MNE). We investigated the predictive value of these together with other demographic and clinical variables for response to first-line treatments in children with MNE.

View Now